首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   304篇
  免费   64篇
  国内免费   10篇
耳鼻咽喉   2篇
儿科学   1篇
妇产科学   7篇
基础医学   58篇
口腔科学   4篇
临床医学   21篇
内科学   72篇
皮肤病学   8篇
神经病学   8篇
特种医学   4篇
外科学   31篇
综合类   27篇
预防医学   16篇
药学   38篇
中国医学   1篇
肿瘤学   80篇
  2024年   6篇
  2023年   25篇
  2022年   47篇
  2021年   54篇
  2020年   45篇
  2019年   33篇
  2018年   41篇
  2017年   18篇
  2016年   19篇
  2015年   9篇
  2014年   21篇
  2013年   8篇
  2012年   12篇
  2011年   12篇
  2010年   8篇
  2009年   10篇
  2008年   3篇
  2007年   4篇
  2006年   3篇
排序方式: 共有378条查询结果,搜索用时 15 毫秒
41.
目的:探讨外周血中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)、系统免疫炎症指数(SII)在甲状腺髓样癌(MTC)中的应用价值。方法:以我院2012年2月至2020年7月收治的MTC患者50例(MTC组)、甲状腺乳头状癌患者50例(PTC组)、健康体检者50例(健康对照组)为研究对象,比较三组患者外周血NLR、MLR、SII水平的差异,并采用受试者工作特征曲线(ROC)分析上述三个指标及其联合检测在MTC中的诊断效能,进一步根据上述三个指标在诊断MTC中的最佳诊断界值分析其与MTC临床病理特征的相关性。结果:比较各组间外周血NLR、MLR、SII水平示:MTC组NLR显著高于PTC组,差异有统计学意义(P<0.05);MTC组MLR、SII水平显著高于PTC组与HC组,差异有统计学意义(P<0.05)。通过ROC曲线分析发现, NLR、MLR、SII单独诊断MTC患者的ROC曲线下面积分别为0.620、0.681、0.634,NLR、MLR、SII三者联合检测ROC曲线下面积为0.726。MLR单独检测及联合检测对MTC的诊断效能高于NLR、SII单独检测(P<0.05)。MTC患者MLR与淋巴结转移及TNM分期有关,比较差异有统计学意义(P<0.05)。结论:NLR、MLR、SII对MTC具有诊断价值,MLR单独检测及联合检测对MTC的诊断效能高于NLR、SII单独检测。MLR与MTC患者淋巴结转移及TNM分期有关。  相似文献   
42.
43.
《Pancreatology》2016,16(6):1080-1084
BackgroundThe systemic inflammation response and immune impairment are closely related to the development and progression of various tumours, such as pancreatic cancer. In this study, we evaluated circulating inflammation factors and circulating regulatory T cells (Tregs) as markers of immunosuppression in a cohort of Chinese patients with resectable pancreatic cancer.MethodsSamples were retrospectively collected from a series of 195 pathological stage I/II pancreatic cancer patients who underwent potentially curative surgery between June 2010 and April 2014. To examine the prognostic factors, circulating systemic inflammation-based markers and Tregs, detected by flow cytometry, were analysed.ResultsUnivariate analyses revealed that the neutrophil-lymphocyte ratio (NLR), TNM stage, differentiation, chemotherapy, CA19-9 levels and presence of Tregs are significantly associated with overall survival in patients with resectable pancreatic cancers. NLR (p = 0.001, HR = 0.538), TNM stage (p = 0.004, HR = 0.593), differentiation (p = 0.011, HR = 0.46), chemotherapy (p = 0.006, HR = 0.516) and Tregs (p = 0.001, HR = 0.558) are identified as independent prognostic markers by multivariate analyses. Interestingly, we also found that high NLR levels combined with a high proportion of Tregs (p < 0.001, HR = 3.521) correlate strongly with worse survival, with a greater than 3.5–fold increased risk of death compared with those with concurrent low levels of NLR and Tregs.ConclusionsThe preoperative NLR and circulating regulatory T cells are potentially independent prognostic factors for overall survival in resectable pancreatic cancer patients. High NLR levels combined with poor immune state before surgery, as measured by Tregs, are associated with an extremely poor prognosis.  相似文献   
44.
目的探讨术前中性粒细胞与淋巴细胞比值(NLR)对急性胆管炎伴胆总管结石患者手术预后评估的临床意义。 方法选取江苏大学附属武进人民医院普外科2016年1月至2019年6月收治的急性胆管炎伴胆总管结石行手术治疗的患者60例为研究对象进行回顾性研究,其中男性27例,女性33例;年龄46~88岁,平均(67.93±11.46)岁。术前NLR <5.435患者作为低NLR组(31例),NLR≥5.435患者作为高NLR组(29例)。比较两组患者术前白细胞计数、C反应蛋白、谷草转氨酶、谷氨酰转肽酶水平;同时分析两组住院总天数、术后住院天数、住院总费用等。 结果低NLR组白细胞计数低于高NLR组[(6.28±1.66)×109/L比(10.59±3.55)×109/L,P<0.05 ];低NLR组C反应蛋白水平低于高NLR组[(57.63±47.68)ug/mL比(81.38±38.25)ug/mL,P<0.05 ];低NLR组谷草转氨酶水平低于高NRL组[(96.17±71.25)U/L比(281.90±438.30)U/L,P<0.05];低NLR组谷氨酰转肽酶水平均低于高NLR组[(297.57±255.97)U/L比(509.70±462.06)U/L,P<0.05],差异有统计学意义(P<0. 05)。低NLR组住院总天数[(13.34±4.55)d比(15.49±3.94)d,P<0.05]、术后住院天数[(10.07±2.80)d比(11.6±3.41)d,P<0.05]及住院总费用[(26 984.78±4 316.30)元比(30 875.35=±4 305.50)元,P<0.05]等均低于高NLR组,差异有统计学意义(P<0. 05)。 结论急性胆管炎伴胆管结石患者外周血NLR值与其炎症感染程度呈正相关,临床上可将NLR作为对其病情及手术预后进行评估的指标。  相似文献   
45.
Objective: The aim of this work was to analyze the clinical characteristics and pretreatment peripheral blood cell counts of patients with hypopharyngeal squamous cell carcinoma (HPSCC) and determine their relationship with clinical outcomes.

Methods: One hundred ninety-seven patients were eligible for the study. The relationship between survival and pretreatment peripheral absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute monocyte count (AMC), neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR) were analyzed by one-way analysis of variance, t-test, and univariate and multivariate analysis.

Results: The median follow-up time was 30.95 months (range 1–82 months). The 3-year disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) rates for all patients were 40.8, 51.0, and 48.1%, respectively. The ANC, AMC, NLR, and LMR were significantly associated with tumor stage and clinical stage (p?NLR (≥2.69) and low LMR (<2.98) were significantly associated with poor DFS, CSS, and OS. The LMR was a significant independent prognostic factor for DFS, CSS, and OS (p?=?.035, .047, and .045, respectively).

Conclusion: The pretreatment LMR should be considered as an independent prognostic factor for patients with HPSCC.  相似文献   
46.
目的探讨中性粒细胞/淋巴细胞比值(NLR)联合尿微量白蛋白/尿肌酐比值(ACR)评估2型糖尿病早期肾损伤的临床价值。方法选取我院2018年1月至2019年5月期间收治的146例2型糖尿病患者,根据是否合并早期肾损伤分为糖尿病组(n=97)和早期糖尿病肾损伤组(n=49),选取同期体检的50例健康人员作为对照组。比较三组的实验室指标,探讨NLR、ACR在2型糖尿病早期肾损伤评估中的价值。结果早期糖尿病肾损伤组、糖尿病组的糖化血红蛋白、空腹血糖、餐后2h血糖、中性粒细胞及尿微量白蛋白均显著高于对照组(P<0.05);早期糖尿病肾损伤组的中性粒细胞、尿微量白蛋白均显著高于糖尿病组(P<0.05)。早期糖尿病肾损伤组的NLR、ACR水平均显著高于糖尿病组及对照组(P<0.05);糖尿病组的NLR、ACR水平与对照组相比,差异无统计学意义(P>0.05)。2型糖尿病早期肾损伤与NLR、ACR水平均呈正相关(r>0, P<0.05)。结论 NLR、ACR均是评估2型糖尿病早期肾损伤的敏感指标,可为疾病的早期诊断及治疗提供重要依据。  相似文献   
47.
目的 探讨中性粒细胞与淋巴细胞比值(NLR)与支气管扩张症(支扩症)急性加重期严重程度的相关性 。方法 回顾性分析2016年1月—2019年4月在本院呼吸科住院治疗的支扩症患者481例,纳入符合入组条件的191例,其中男性75例,女性116例,年龄17~86岁,平均(59.23±13.34)岁。分析NLR、血红蛋白(HB)、血小板与淋巴细胞比值(PLR)、C反应蛋白(CRP)和支气管扩张严重程度(bronchiectasis severity index,BSI)以及FAECD积分的相关性;用多重线性回归分析法分别分析BSI及FACED积分的影响因素;分别根据支气管扩张严重程度(BSI)、FACED积分将入组患者分为轻、中、重组,用单因素方差分析NLR在不同组之间的差异 。结果 血清NLR(r=0.67)、PLR(r=0.45)、CRP(r=0.56) 和BSI积分呈正相关(P值均<0.01)。血清NLR(r=0.53)、PLR(r=0.43)、CRP(r=0.45)和FACED积分呈正相关(P值均<0.01)。多重线性回归分析显示:NLR(β系数1.29,95%CI 0.95~1.72,P=0.01)、CRP(β系数1.24,95%CI 0.68~1.55,P<0.01)对BSI积分的影响均有统计学意义,NLR(β系数1.25,95%CI 0.70~1.66,P=0.02)、CRP(β系数1.20,95%CI 0.53~1.60,P=0.01)对FACED积分的影响均有统计学意义。BSI及FACED积分越高NLR水平越高,NLR分别在两种积分不同严重程度组间差别均有统计学意义(P值均<0.05)。结论 NLR是预测支扩症急性加重期严重程度的有用指标。  相似文献   
48.

Purpose

To identify clinical parameters that are prognostic for improved overall survival (OS) after yttrium-90 radioembolization (RE) in patients with liver metastases from colorectal cancer (CRC).

Materials and Methods

A total of 131 patients who underwent RE for liver metastases from CRC, treated at 2 academic centers, were reviewed. Twenty-one baseline pretreatment clinical factors were analyzed in relation to OS by the Kaplan-Meier method along with log-rank tests and univariate and multivariate Cox regression analyses.

Results

The median OS from first RE procedure was 10.7 months (95% confidence interval [CI], 9.4–12.7 months). Several pretreatment factors, including lower carcinoembryonic antigen (CEA; ≤20 ng/mL), lower aspartate transaminase (AST; ≤40 IU/L), neutrophil-lymphocyte ratio (NLR) <5, and absence of extrahepatic disease at baseline were associated with significantly improved OS after RE, compared with high CEA (>20 ng/mL), high AST (>40 IU/L), NLR ≥5, and extrahepatic metastases (P values of <.001, <.001, .0001, and .04, respectively). On multivariate analysis, higher CEA, higher AST, NLR ≥5, extrahepatic disease, and larger volume of liver metastases remained independently associated with risk of death (hazard ratios of 1.63, 2.06, 2.22, 1.48, and 1.02, respectively).

Conclusions

The prognosis of patients with metastases from CRC is impacted by a complex set of clinical parameters. This analysis of pretreatment factors identified lower AST, lower CEA, lower NLR, and lower tumor burden (intra- or extrahepatic) to be independently associated with higher survival after hepatic RE. Optimal selection of patients with CRC liver metastases may improve survival rates after administration of yttrium-90.  相似文献   
49.
越来越多的研究表明,炎性指标,如中性粒细胞与淋巴细胞比值(neutrophil-to-lymphocyte ratio,NLR)可作为肿瘤进展和预后的重要评判依据。由于NLR是一种廉价易得的炎性标志物,具有获取的便利性和较高的临床参考价值,逐渐为人们所重视。本文将根据文献报道就NLR与各类肿瘤进展及预后的关系作一综述。  相似文献   
50.

Introduction

Although eribulin and nab-paclitaxel are chemotherapy agents widely used for locally advanced or metastatic breast cancer (MBC), their predictive factors remain unknown. Because the absolute neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic factor for early-stage breast cancer, we investigated its usefulness in terms of the eribulin or nab-paclitaxel treatment efficacy for MBC.

Patients and Methods

A total of 85 patients with MBC treated with eribulin (n = 59) or nab-paclitaxel (n = 26) were recruited. NLR values were collected at baseline, after 1 cycle, after 2 cycles, and at the end of treatment. The NLR cutoff value was set at 3.

Results

The progression-free survival (PFS) of patients with an NLR < 3 at baseline (median, 242 days; n = 24) was significantly better than that of patients with an NLR of ≥ 3 (median, 98 days; n = 35; hazard ratio, 0.37, 95% confidence interval, 0.18-0.71; P = .0032). Similarly, the overall survival was marginally significantly better in patients with an NLR < 3 who were treated with eribulin (P = .058). However, the NLR was not significantly associated with PFS or overall survival for patients treated with nab-paclitaxel. No significant association was found between the NLR during treatment and PFS in the eribulin group. The significance of the NLR for the efficacy of eribulin was consistent, irrespective of estrogen receptor status, previous anthracycline or endocrine use, and the number of previous chemotherapy regimens.

Conclusion

A low NLR at baseline was significantly associated with improved PFS in patients treated with eribulin but not in those treated with nab-paclitaxel. Therefore, the baseline NLR might be clinically useful for selecting patients who would benefit from eribulin.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号